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Wadsack C, Tabano S, Maier A, Hiden U, Alvino G, Cozzi V,
Hu¨ttinger M, Schneider WJ, Lang U, Cetin I, Desoye G. Intrauter-
ine growth restriction is associated with alterations in placental
lipoprotein receptors and maternal lipoprotein composition. Am J
Physiol Endocrinol Metab 292: E476–E484, 2007. First published
September 26, 2006; doi:10.1152/ajpendo.00547.2005.—Among
other factors, fetal growth requires maternal supply of cholesterol.
Cellular cholesterol uptake is mainly mediated by the LDL receptor
(LDL-R) and the scavenger receptor family. We hypothesized that
expression levels of key receptors of these families were regulated
differently in placentas from IUGR pregnancies with varying degrees
of severity. Third-trimester placentas from IUGR pregnancies with
(IUGR-S) and without (IUGR-M) fetal hemodynamic changes and
from control (AGA) pregnancies were studied. LDL-R, LDL-R-
related protein (LRP-1), and scavenger receptor class B type I (SR-BI)
mRNA and protein levels were measured. Cholesterol concentration
and composition of lipoproteins were analyzed enzymatically and by
lipid electrophoresis, respectively, in maternal and umbilical cord
blood. LDL-R mRNA levels in IUGR-M were similar to AGA but
lower (P ! 0.05) in IUGR-S. In contrast, LDL-R protein was twofold
(IUGR-M) and 1.8-fold (IUGR-S) higher (P ! 0.05) than in the AGA
group. LRP-1 mRNA and protein levels were not altered in the IUGR
cases. SR-BI mRNA was unchanged in IUGR, but protein levels were
lower (P ! 0.05) in IUGR-S than in the other groups. Maternal
plasma concentrations of LDL cholesterol were higher (P ! 0.05) in
the AGA group (188.5 " 23.6 mg/dl) than in the IUGR-S group
(154.2 " 26.1). Electrophoretic mobility of the LDL fraction in
maternal plasma demonstrated significant changes in migration to-
ward higher values (AGA 0.95 " 0.06, IUGR-M 1.12 " 0.11, P !
0.001; IUGR-S 1.28 " 0.20, P # 0.002). We conclude that LDL-R
and SR-BI levels are altered in IUGR pregnancies. These differences
were associated with changes in LDL, but not HDL, mobility and
cholesterol concentration in maternal circulation.
pregnancy; placenta; lipids; fetal growth
CHOLESTEROL HAS MULTIPLE BIOLOGICAL ROLES that include its
functioning as a structural membrane component, precursor for
steroid synthesis, and activator of various cellular processes
(42). Extensive steroid hormone synthesis in the placenta and
the rapid growth and development of the fetus make pregnancy
a condition of high cholesterol demand in the feto-placental
unit (23). In humans, both placental tissue (39) and fetal organs
(5) have the capacity for de novo cholesterol synthesis. How-
ever, the high cholesterol demand in the fetal tissues may not
be fully satisfied by endogenous means. A significantly higher
cholesterol concentration in the umbilical vein compared with
the arteries (33) suggests transfer from maternal or placental
sources to the fetus. In the third trimester of gestation, mater-
nally-derived cholesterol reportedly contributes $22–40% to
the fetal cholesterol pool (14, 24). However, this remains
controversial (25). The molecular mechanisms accounting for
the uptake of maternal cholesterol into the placenta, mainly as
lipoprotein-associated cholesterol (42), and for subsequent
transfer, if any, into the fetal circulation, are as yet poorly
understood.
Cellular uptake of maternal low-density lipoprotein (LDL),
high-density lipoprotein (HDL), and very low-density lipopro-
tein (VLDL) is mainly mediated by two receptor families, LDL
receptor (LDL-R) and the scavenger receptor family. In the
human placenta, binding sites for LDL (16), VLDL, (41) and
HDL (1) have been identified on the microvillous membrane of
the syncytiotrophoblast. LDL-R-related protein (LRP-1) is a
multiligand cell-surface receptor expressed in trophoblast dur-
ing gestation (8) that binds apolipoprotein E-containing parti-
cles (4), such as VLDL. Because of the profound increase in
circulating maternal VLDL with advanced gestation (40), syn-
cytiotrophoblast LRP-1 may play a role in acquiring choles-
terol for metabolic needs of both placenta and fetus (11, 36).
Scavenger receptors bind modified LDL as well as HDL
(27). Recently, a developmental change in placental expression
of the scavenger receptor class B type I (SR-BI), a high-affinity
receptor for HDL, has been described with decreasing protein
expression from the first to the third trimester (38).
Intrauterine growth restriction (IUGR) is a condition often
associated with a decreased supply of nutrients and/or oxygen
to the growing conceptus. Due to placental failure, an adequate
provision of the fetus with oxygen and nutrients may result
(21). Alterations in expression levels of placental lipoprotein
receptors could be associated with changes in their uptake or
efflux functions and might contribute to altered lipid levels in
the fetal circulation in pregnancies characterized by IUGR,
hence, contributing to poor fetal growth (6).
We hypothesized that the expression levels of lipoprotein
receptors involved in cholesterol uptake and metabolism may
be downregulated in placentas from IUGR pregnancies. Fur-
thermore, the degree of downregulation might correlate with
the severity of the pathology. Lipoprotein particles are heter-
ogeneous in size, density, electric charge, and chemical com-
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position. These heterogeneities, which are due to environmen-
tal factors, such as the fatty acid content of the diet (22), may
also modulate fetal development. Therefore, in this study we
investigated placental expression of receptors for the major
lipoproteins involved in cholesterol uptake as well as maternal
and fetal lipoprotein composition in IUGR pregnancies. We
have related the observed changes to the severity of the
pathology as represented by hemodynamic changes in the
IUGR fetuses.
SUBJECTS AND METHODS
Subjects. Placental and blood samples were obtained from IUGR
and appropriate-for-gestational-age (AGA) pregnancies. Gestational
age was calculated from the last menstrual period and confirmed by an
ultrasonographic examination performed before 20 wk of gestation.
Babies with morphological malformations at birth and/or chromo-
somal abnormalities were excluded from the study. Mothers were
excluded if they had obstetrical complications (hypertension, diabetes
mellitus, or gestational diabetes) or factors predisposing to IUGR.
Control pregnancies (AGA) were women who gave birth to healthy-
term neonates with a birth weight between the 10th and 90th percen-
tile according to Italian standards for birth weight and gestational age
(19).
IUGR was defined on the basis of ultrasound measurements of the
abdominal circumference with values below the 10th percentile of
reference values, together with a percentile reduction %40% com-
pared with the previous measurement of abdominal circumference and
birth weight below the 10th percentile according to Italian standards
for birth weight and gestational age (19). Intrauterine growth-re-
stricted fetuses were divided into two groups according to Doppler
velocimetry of the umbilical artery: IUGR-M was composed of
fetuses with normal pulsatility index (PI); IUGR-S had abnormal PI
(20). All women delivered by elective caesarean section.
At delivery placentas were trimmed free of membranes, and three
pieces were excised such that they contained tissue from both the fetal
and maternal side. After being washed in physiological saline con-
taining EDTA to eliminate excess blood, they were stored at &80°C
within 30 min.
Informed consent was obtained from the patients, and the ethics
committee of the Medical Faculty, University of Milan, granted
ethical approval.
Blood samples. Blood samples were collected at the time of
delivery from a maternal brachial vein after a 12-h overnight fast as
well as from umbilical artery and vein in tubes containing 1.0 mg/ml
Na2EDTA. Plasma was harvested by immediate centrifugation (4,000
rpm) in a bench centrifuge at 4°C for 10 min and stored at &80°C
until electrophoretic analysis. Aliquots of plasma were used immedi-
ately for measurements of plasma LDL- (LDL-C) and HDL-choles-
terol (HDL-C) concentration using commercially available enzymatic
reagents for quantitative cholesterol determination (Wako Chemicals,
Neuss, Germany).
Materials. Primers for LDL-R, LRP-1, and the ribosomal protein
L30 were selected using the software Primer 3 that is available online
at http://www-genome.wi.mit.edu. For LDL-R, they were forward
primer (F): 5'-TGG CAT CAC CCT AGA TCT CC-3', reverse primer
(R): 5'-GGT GGT CCT CTC ACA CCA GT-3', amplifying a 323-bp
fragment; for LRP-1, they were F: 5'-ACC TGC CAG ATC CAG
AGC TA-3'’27', R: 5'-CTC TGG CTG AGG TGG AAG TC-3',
amplifying a 270-bp fragment; for SR-BI, they were F: 5'-AAA TCC
GGA GCC AAG TAG GT-3', R: 5'-CCA GAA CAG GCA GAG
TAG TGG-3', amplifying a 231-bp fragment; for L30, they were F:
5'-CCT AAG GCA GGA AGA TGG TG-3', R: 5'-CAG TCT GTT
CTG GCA TGC TT-3', amplifying a 351-bp fragment.
In a microarray analysis (Affymetrix U133A) of isolated first-
trimester and term trophoblasts and placental endothelial cells (12),
the ribosomal protein L30 was most stably expressed among various
housekeeping genes and, hence, was used here in RT-PCR. All primer
pairs were chosen to span exons to avoid amplification of traces of
potentially contaminating DNA.
Rabbit antiserum against a synthetic peptide, corresponding to the
linker region between the ligand binding repeats 4 and 5 of the human
LDL-R (CRGLYVFQGDSSPC), was used. CRGLYVFQGDSSP and
RGLYVFQGDSSPC were coupled to keyhole limpet hemocyanin via
the respective cysteines, and a 1:1 mixture (250 (g of each peptide)
was injected three times on days 0, 21, and 35. The antiserum was
obtained on day 42. The LRP-1 antiserum was raised in rabbits against
an intracellular peptide of LRP-1 (amino acid 4532 to 4544). Anti-
bodies for SR-BI (rabbit, polyclonal) and )-actin (mouse, monoclo-
nal) were purchased from Abcam (Novus Biologicals, Cambridge,
UK). The secondary antibody used for SR-BI and )-actin detection,
respectively, was goat anti-rabbit or anti-mouse HRP conjugate (Bio-
Rad, Hercules, CA).
RNA extraction and one-step RT-PCR. After extraction [carried out
with the phenol and guanidine thiocyanate method (7)] and quantifi-
cation, 500 ng of total RNA were reverse transcribed, and the
gene-specific cDNA was amplified in the same reaction using the
One-Step RT-PCR kit (Qiagen, Vienna, Austria). PCR products were
separated on a 3% agarose gel, and the resulting bands were scanned
for optical density using the Alpha EaseFC software (AlphaInnotech,
version 3.2.3). Since different amplification conditions had to be
applied for targets (LDL-R and LRP-1) and housekeeping gene (L30),
reactions were performed in separate tubes. After reverse transcription
at 50°C for 30 min and hot-start Taq polymerase activation at 95°C for
15 min, the cycle parameters were as follows: LDL-R: 29 cycles of
amplification at 94°C for 30 s, 58°C for 60 s, and 72°C for 60 s;
Table 1. Clinical features of the study subjects
Clinical Data AGA (18 cases) IUGR-M (8 cases) IUGR-S (12 cases)
P Value
IUGR-M vs.
AGA
IUGR-S vs.
AGA
Mother
Age, yr 33 (22–41) 35 (30–45) 33 (23–40) NS NS
Weeks of gestation, wk * days 39*2 (38–40*6) 37 (33*2–38*4) 33*4 (27–38*5) 0.00014 0.00001
BMI at the beginning of pregnancy* 21.9 (18.2–27.5) 20.2 (16.2–26.2) 24.1 (18.9–37.1) NS NS
Conceptus
Fetal weight, g 3,284 (2,880–3,900) 1,750 (1,370–2,430) 1,380 (620–2,280) 0.00000001 0.000000001
Placental weight, g 498 (370–700) 263 (175–412) 259 (139–456) 0.000001 0.0000003
Fetal ponderal index† 26.3 (23.8–31.6) 24.7 (23.5–26.5) 14.8 (12.6–17.0) NS 0.000004
Values are given as median (range). AGA, appropriate for gestational age; IUGR, intrauterine growth restriction; NS, not significant; BMI, body mass index
(P % 0.05). The IUGR group was classified into 2 subgroups (IUGR-M, IUGR-S) according to pulsatility index (PI) obtained by ultrasound measurements.
*BMI # weight (kg)/height (m2). †Ponderal index # kg/length (m3).
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LRP-1: 30 cycles of amplification at 94°C for 30 s, 57°C for 60 s, and
72°C for 60 s; SR-BI: 30 cycles of amplification at 94°C for 30 s,
59°C for 60 s, and 72°C for 60 s; L30: 28 cycles of amplification at
94°C for 30 s, 58°C for 40 s, and 72°C for 60 s. Each experiment was
performed in duplicate.
Protein extraction and Western blot analysis. Proteins used in
Western blot experiments were extracted from tissues by a standard
method. Aliquots of protein (30 (g) quantified by the method of
Lowry et al. (15) were loaded onto and separated on either 10
(LDL-R, LRP-1) or 4–12% (SR-BI) PAGE Precast Duramide gels
(Cambrex Biosciences Rockland, Rockland, ME) under reducing
conditions. They were subsequently transferred to a nitrocellulose
membrane (Amersham Biosciences, Little Chalfont, UK) by blotting
for 1.5 h at a constant voltage of 25 V. The nitrocellulose filters were
incubated overnight with the primary antibody, washed, and incubated
with the secondary peroxidase-labeled IgG for 1.5 h. Proteins were
detected on autoradiography film using an enhanced chemilumines-
cence detection kit (Amersham Biosciences). After treatment with
Restore Western blot stripping buffer (Pierce), filters were reincubated
with )-actin antibody to correct for loading. The bands on the films
were densitometrically scanned as described above.
Lipoprotein electrophoresis. Electrophoretic mobility was deter-
mined on 0.5% agarose gels, as described by Sparks and Phillips (32).
Samples (6 (l) loaded onto the gel were electrophoresed at 25 mA for
90 min using a 0.06-M barbital buffer (pH 8.6; Merck). The gels were
then fixed in 0.5% 5-sulfosalicylic acid dihydrate solution (Roth) for
30 min and washed for 10 min in distilled water. They were dried
overnight at room temperature and stained with 1% Sudan Black B
(Fluka) in 60% ethanol (Merck). Migration distance was measured
from the loading point to the front of the stained band. Relative
electrophoretic mobility (Rf) was calculated as the ratio of migration
distance of +- or )-band relative to 5 (l of control LDL (0.7 mg
protein/ml) or HDL3 (1.0 mg protein/ml) both isolated by sequential
ultracentrifugation (31) from an age-matched healthy human pregnant
female donor.
Data analysis. An AGA “control sample” was included in each
RT-PCR and Western blot experiment to make possible the compar-
ison of results obtained on different gels and blots. It represents an
internal standard prepared from a pool of three fresh AGA term
placentas. The coefficient of variation between the intensities of bands
obtained by PCR and immunoblotting for the internal standard was 21
and 28%, 17 and 18%, and 12 and 16% for LDL-R, LRP, and SR-BI,
respectively. In RT-PCR experiments the expression values for each
sample were calculated as the ratio between LDL-R, LRP-1, or SR-BI
and L30 intensity of the band normalized to the same ratio of the AGA
control sample. Similarly, the amount of LDL-R, LRP-1, and SR-BI
protein from Western blot experiments was normalized to the )-actin
level for each sample and then normalized to the AGA control sample.
All statistical analyses were performed using the SigmaStat for
Windows (version 2.03) statistical software package (Access Softek,
San Rafael, CA). After testing for normal distribution, ANOVA
between the groups and Tukey’s post hoc test were used. Linear
correlation analyses (Pearson product moment correlation) were used
to test for association between maternal, fetal, and all lipoprotein
variables as well as for testing of gestational age-dependent changes
in mRNA and protein levels. Significances were accepted with P !
0.05. Unless stated otherwise, data are presented as means " SD.
RESULTS
Characteristics of the study subjects. Table 1 summarizes
demographic and obstetrical characteristics of subjects with
normally grown and growth-restricted fetuses. As expected,
IUGR pregnancies had significantly lower fetal and placental
weights than AGA; IUGR-S fetuses had lower fetal ponderalTa
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indexes (Table 1). No significant differences were observed
between IUGR-M and IUGR-S in these variables. Specific
oxygenation values were different in IUGR-S compared with
AGA; PO2 values were significantly lower, whereas PCO2 and
Hb values were significantly higher in IUGR-S; moreover,
lactate concentrations tended to increase in IUGR-S (Table 2).
LDL-R and LRP-1. RT-PCR for LDL-R mRNA resulted in
a single product of 322 bp (Fig. 1A). Transcriptional expression
levels in IUGR-M [0.83 " 0.50 arbitrary units (AU)] were
similar to those of the AGA group (0.81 " 0.82 AU), whereas
mRNA levels were lower (P ! 0.05) in IUGR-S (0.19 " 0.18
AU) than in IUGR-M and AGA (Fig. 1B) by 75%. Western
blot analysis of tissue samples identified two LDL-R bands at
apparent molecular masses of 160 and 120 kDa. The 120-kDa
protein band was more prominent and is in accordance with
analyses of immunoprecipitates of the LDL-R from normal
fibroblasts, which demonstrate that the receptor is detected first
as a precursor of apparent 120 kDa (Fig. 1C). The precursor is
converted to a mature form of apparent 160 kDa (9). Protein
levels were higher in the IUGR-M (2.24 " 0.67 AU, P !
0.001) and IUGR-S (1.81 " 0.54 AU, P ! 0.05) groups than
in the AGA group (1.05 " 0.47) (Fig. 1D). No significant
relationship was observed between LDL-R expression and
gestational age (data not shown).
Fig. 1. A: semiquantitative RT-PCR for LDL receptor (LDL-R)
in the various groups produced a single band of 322 bp in size.
Individual data were normalized to both L30 mRNA and to an
internal control included on each blot. B: the median value
(horizontal line) in the box plot of intrauterine growth restriction
IUGR-S (n # 9) is decreased vs. IUGR-M (n # 5) and appro-
priate for gestational age (AGA; n # 11). C: Western blot
analysis of tissue samples identified 2 LDL-R bands with appar-
ent molecular masses of 160 (mature form) and 120 kDa (pre-
cursor), with the 120-kDa protein being more prominent. D:
mean LDL-R expression (horizontal line) was significantly in-
creased in IUGR-M and IUGR-S compared with the AGA group.
Individual data were normalized to )-actin and to the internal
control in each blot.
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RT-PCR for LRP-1 resulted in a single product of correct
size at 269 bp (Fig. 2A). Similar mRNA levels were found in
both IUGR-M (1.28 " 0.24 AU) and IUGR-S (1.10 " 0.14
AU) compared with the AGA group (1.39 " 0.26 AU) (Fig.
2B). Moreover, a considerable variability on transcriptional
levels was observed in the AGA group. Unaltered placental
LRP-1 mRNA in the various groups was paralleled at the
protein level (Fig. 2C). LRP-1 protein expression in the AGA,
IUGR-M, and IUGR-S groups was 0.73 " 0.12, 0.72 " 0.20,
and 0.65 " 0.21, respectively (Fig. 2D). No significant rela-
tionship was observed between LRP-1 expression and gesta-
tional age (data not shown).
SR-BI. SR-BI mRNA was detected by RT-PCR in tissue
samples of all groups with a product of 231 bp in length (Fig.
3A). No quantitative differences were found between the
IUGR-M (0.86 " 0.12) and IUGR-S (0.81 " 0.16) compared
with AGA group (0.94" 0.35) (Fig. 3B). The antibody used to
probe Western blot experiments revealed an 82-kDa SR-BI
band in placentas, in agreement with published values for
isolated trophoblasts (38) and other tissues (27) (Fig. 3C).
Expression levels in IUGR-M (0.79 " 0.25 AU) resembled
those of the AGA group (0.94 " 0.40 AU), but those of
IUGR-S (0.53 " 0.20 AU) were lower (P ! 0.05) than in
IUGR-M and AGA by about 50% (Fig. 3D). The expression
Fig. 2. A: semiquantitative RT-PCR for LDL-R-related pro-
tein (LRP-1) in the various groups produced a single band of
269 bp in size. Individual data were normalized to both L30
mRNA and to an internal control. B: the median values
(horizontal line) in the box plots do not differ significantly
between the groups (AGA n # 18, IUGR-M n # 8, IUGR-S
n # 12). C: representative immunoblot of LRP-1 revealed 1
strong band at 85 kDa in each group, representing the trans-
membrane )-subunit of the protein. Individual data were
normalized to )-actin and to the internal control in each blot.
D: mean values (horizontal line) in the IUGR groups showed
no expression differences compared with the control group.
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levels of SR-BI did not correlate with any other maternal or
fetal clinical parameter either in the separate subgroups or in
the total population (AGA * IUGR; data not shown). Expres-
sion of SR-BI was not related to gestational age (data not
shown).
Lipoprotein electrophoresis and lipoprotein cholesterol. In
the AGA group (n # 11) the relative electrophoretic mobilities
(Rf values) in maternal plasma were 0.95 " 0.06 [determined
as the sample to LDL migration distance ratio ()-band)] and
1.03 " 0.06 [determined as the sample to HDL3 migration
distance ratio (+-band)], respectively. They were similar to the
values in the arterial ()-band: 0.96 " 0.11, +-band: 1.04 "
0.04) and venous ()-band: 0.98 " 0.09, +-band: 1.16 " 0.01)
umbilical cord plasma (data not shown). In maternal plasma
the )-band showed a significant change in mobility toward
higher values in IUGR-S (n # 9), as reflected by higher Rf
values [IUGR-M (n # 8) 1.12 " 0.11, P ! 0.001; IUGR-S
1.28 " 0.20, P # 0.002] (Fig. 4). Rf values in the umbilical
cord of this sample collection did not differ among the groups.
Maternal plasma concentrations of LDL-C were highest in
the AGA group (188.5 " 23.6 mg/dl) compared with the
IUGR-S group (154.2 " 26.1 mg/dl) (P # 0.049) and the
IUGR-M group (176.6 " 19.1 mg/dl). No difference could be
observed in the arterial and venous cord plasma either for the
Fig. 3. A: identification of scavenger receptor class B type I
(SR-BI) mRNA by RT-PCR revealed a single band of 231 bp in
size. B: box blots of SR-BI mRNA levels revealed no significant
differences among the groups. C: representative Western blot for
AGA and IUGR groups of different severity showed a strong band
at 82 kDa representing SR-BI. D: individual data were normalized
to )-actin and to the internal control in each blot. The mean value
(horizontal line) of IUGR-S (n # 12) and IUGR-M (n # 8) is
significantly decreased vs. AGA (n # 18).
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separate or for the combined (arterial: 48.4 " 7.1 mg/dl;
venous: 43.4 " 5.3 mg/dl) study groups. When the maternal
plasma concentrations of all three populations were considered
together, the only significant correlation was found between
)-Rf values and LDL-C (r # &0.58, P # 0.0039), which
indicates changes in the lipid-to-protein ratio in LDL particles
on the maternal side.
The maternal Rf values of the +-bands in both IUGR groups
(IUGR-M 1.03 " 0.06 and IUGR-S 1.03 " 0.04) were similar
to those of the AGA group (1.03" 0.05; Fig. 4). Electrophore-
sis of cord blood samples showed similar Rf values for the +-
and )-bands in both IUGR groups and no difference in the
maternal and cord blood values of the AGA group (data not
shown). HDL-C concentrations in maternal (AGA * IUGR
groups: 56.0 " 3.8 mg/dl) as well as fetal (AGA * IUGR
groups: 24.3 " 3.3 mg/dl) plasma did not differ between the
groups (data not shown).
DISCUSSION
The presence of lipoprotein receptors in the placenta indi-
cates the potential for fetal tissues to take up cholesterol from
maternal lipoproteins. The present study demonstrates an al-
tered expression of distinct lipoprotein receptors in IUGR
compared with AGA placentas. In particular, this was found
for LDL-R and SR-BI, two key receptors for the placental
uptake of cholesterol from maternal LDL and/or HDL.
Changes in lipoprotein receptors are not a general phenomenon
associated with IUGR, since LRP-1 expression levels are not
affected in the same IUGR patients. Because of a reciprocal
relationship in LDL-R and LRP-1 levels (11), LRP-1 was
included in the study to identify any compensatory changes for
the alterations in LDL-R. However, absence of the predicted
changes suggests that the mechanism resulting in the reciprocal
changes in LDL-R and LRP-1 is not operative in the IUGR
placenta.
Contrary to our findings, increased LDL-R mRNA levels
have previously been reported in IUGR compared with AGA
term and preterm placentas (35). Different criteria in selecting
the study populations may account for these differences. In
both studies IUGR was diagnosed in utero by biometric ultra-
sound, but the full range of IUGR severity as reflected by
hemodynamic changes in the umbilical circulation was in-
cluded only in the present study. These different findings
underline the influence of the severity and stage of the IUGR
condition. To our knowledge, this is the first study investigat-
ing differences in the expression of placental receptors between
AGA and IUGR pregnancies classified on the basis of IUGR
severity. A further difference in study design was the analysis
of placental tissue obtained exclusively from elective caesarean
sections, which in terms of gene expression may be more
representative of the condition of the placenta during preg-
nancy than samples taken at the end of pregnancy after vaginal
delivery, which is associated with higher fetal distress. It is
pertinent that fetal cord blood lipids in uncomplicated preg-
nancies were significantly affected by mode of delivery (28,
45), which may have marked effects on placental function.
The discordant changes in LDL-R mRNA and protein con-
form to the complex mode of regulation of LDL-R protein at
the level of synthesis, posttranslational processing, and degra-
dation and may suggest a concomitant downregulation of
PCSK9. This proteinase is critical for the degradation and,
hence, turnover of LDL-R protein (3).
In contrast to LDL-R, SR-BI protein levels were profoundly
reduced in the severe IUGR group (Fig. 3). One potential bias
of our study is that IUGR pregnancies were delivered at an
earlier gestational age than controls, because it is very rare to
obtain placental samples from normal pregnancies delivered
preterm for indications other than fetal. However, we did not
observe any relationship between translational levels of LDL-R
and SR-BI and gestational age. Moreover, inferences can be
made from developmental changes in SR-BI protein expression
levels, which decrease with gestational age (38). This would
predict higher levels in earlier periods compared with the end
of gestation. Therefore, it appears unlikely that the gestational
age differences account for the differences in SR-BI expression
levels. Similar inferences cannot be made for LDL-R because
of conflicting studies reporting an increased (18), decreased
(43), or unchanged (35) LDL-R expression on transcriptional
as well as translational levels during gestation.
Not only are the receptor protein expression levels different
in IUGR, but the composition and concentration of some
maternal lipoproteins also differ. Several techniques have been
employed to separate the plasma lipoproteins, including ultra-
Fig. 4. Lipid electrophoresis of maternal plasma in AGA (n # 18), IUGR-M
(n # 8), and IUGR-S (n # 12) subjects. A: origin and migration positions of
+-migrating (HDL) and )-migrating (LDL) lipoproteins are indicated and
native LDL and HDL3 included as controls. The AGA plasma lipoproteins
showed typical +- and )-migrating LDL and HDL, respectively. In the
IUGR-M group, the )-fraction showed a slightly higher migrating LDL than
native control LDL, whereas no differences in the +-migrating fraction were
found. In the IUGR-S group, the )-lipoprotein mobility was increased com-
pared with native control LDL, but no differences could be observed in the
+-fraction. Two representative experiments with 1 plasma of each group. B: Rf
values (mean # horizontal line) of maternal LDL and HDL in the various
groups calculated as the distance ratios of LDL or HDL bands, respectively, to
control lipoprotein band.
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centrifugation and electrophoresis. Electrophoretic mobility on
agarose gels of small amounts of maternal and fetal plasma can
be used as a proxy measure for the lipid-to-protein ratio in
lipoproteins (32). An increase in the Rf values of the )-spots
reflecting their electrophoretic mobility was positively corre-
lated with the severity of IUGR. The unchanged Rf values of
the particles in the arterial and venous cord plasma were in line
with their comparable concentrations of LDL- and HDL-C.
This finding of absent or only small umbilical venous-arterial
differences in cholesterol concentrations varies from other
studies (33) and may reflect too small subject collectives.
The electrophoretic mobility of the )-lipoproteins, which are
mainly LDL particles, depends on particle size, electric charge,
density, and chemical composition (17) and may be modified
by diet (2) and altered in pathological conditions such as
atherosclerosis (34), diabetes (44), or hypercholesterolemia
(37). Plasma apolipoprotein (26), lipoprotein, and fatty acid
concentrations between normal and IUGR pregnancies (6, 28)
differ in maternal sera, and this may lead to the changes in
lipoprotein composition. In IUGR, LDL particles were signif-
icantly enriched in cholesteryl ester and depleted in free cho-
lesterol (30). These observations are in line with an increase in
the Rf values of the )-spots in association with a significant
decrease in LDL-C concentrations found here. This reflects a
modified composition in the hydrophobic core of the LDL
particle. In the present study, we have confirmed decreased
cholesterol levels in fetal compared with maternal blood (28)
and significantly lower LDL-C concentrations in IUGR (30).
The changes are specific for LDL since, in contrast, Rf values
of HDL particles and maternal as well as fetal HDL-C were
unaltered. Therefore, maternal LDL appears to be more sus-
ceptible than HDL to influences by the IUGR pathology.
The physiological consequences of the regulation of recep-
tors for placental function and fetal development are unclear. A
yet undefined proportion of cholesterol taken up by the pla-
centa may be released into the fetal circulation. The remaining
placental cholesterol, however, is used for sterol synthesis,
foremost of progesterone (13, 39). Provided that cholesterol
taken up by LDL-R and SR-BI contribute to the same intra-
cellular cholesterol pool, the LDL-R upregulation may repre-
sent a mechanism to compensate for the reduced cholesterol
uptake mediated by SR-BI. However, this may be insufficient,
since IUGR in general is accompanied by reduced maternal
progesterone concentrations (29).
An association of placental receptor expression levels with
fetal or placental weight could not be observed here; however,
in IUGR, abnormal lipoprotein metabolism may be a factor
underlying poor fetal growth (26). Maternal LDL levels, i.e.,
both LDL protein and cholesterol, which normally increase by
$60% during uncomplicated pregnancies (10), fail to rise
appropriately in pregnancies complicated by IUGR. As a
result, despite increased translational levels of the receptor in
the placenta, cholesterol provision for steroid synthesis and
supply to the fetus may be insufficient (30).
In conclusion, this study provides evidence for specific
changes in receptors involved in placental uptake of maternal
cholesterol-rich lipoproteins. These differences are evident in
IUGR associated with changes in the fetal circulation, sugges-
tive of placental failure (21). The differential changes in
LDL-R and SR-BI in IUGR warrant further investigation into
placental lipid uptake and sequestration in healthy and patho-
logical pregnancy.
ACKNOWLEDGMENTS
We are indebted to Dr. Peter Dodds, Imperial College at Wye, for his expert
criticism and careful reading of the manuscript. The expert technical assistance
of Birgit Hirschmugl, Graz, is gratefully acknowledged.
GRANTS
The studies reported herein have been carried out with financial support
from the Commission of the European Communities within the RTD program
“Quality of Life and Living Resources” and Grant QLK1–2001-00138 “Influ-
ence of Dietary Fatty Acids on the Pathophysiology of Intrauterine Foetal
Growth and Neonatal Development.” It does not necessarily reflect the Com-
mission’s views and in no way anticipates its future policy in this area. Further
financial support came from the Jubilee Fund, Austrian National Bank, Vienna
Grants 11165 (to C. Wadsack), 10896 (to U. Hiden), and 10053 (to G.
Desoye).
REFERENCES
1. Alsat E, Malassine A. High density lipoprotein interaction with human
placenta: biochemical and ultrastructural characterization of binding to
microvillous receptor and lack of internalization. Mol Cell Endocrinol 77:
97–108, 1991.
2. Archer WR, Lamarche B, St-Pierre AC, Mauger JF, Deriaz O,
Landry N, Corneau L, Despres JP, Bergeron J, Couture P, Bergeron
N. High carbohydrate and high monounsaturated fatty acid diets similarly
affect LDL electrophoretic characteristics in men who are losing weight.
J Nutr 133: 3124–3129, 2003.
3. Attie AD, Seidah NG. Dual regulation of the LDL receptor—some clarity
and new questions. Cell Metab 1: 290–292, 2005.
4. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-
receptor-related protein, LRP, is an apolipoprotein E-binding protein.
Nature 341: 162–164, 1989.
5. Carr BR, Simpson ER. Cholesterol synthesis in human fetal tissues.
J Clin Endocrinol Metab 55: 447–452, 1982.
6. Cetin I, Giovannini N, Alvino G, Agostoni C, Riva E, Giovannini M,
Pardi G. Intrauterine growth restriction is associated with changes in
polyunsaturated fatty acid fetal-maternal relationships. Pediatr Res 52:
750–755, 2002.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem
162: 156–159, 1987.
8. Coukos G, Gafvels ME, Wisel S, Ruelaz EA, Strickland DK, Strauss
JF 3rd, Coutifaris C. Expression of alpha 2-macroglobulin receptor/low
density lipoprotein receptor-related protein and the 39-kd receptor-asso-
ciated protein in human trophoblasts. Am J Pathol 144: 383–392, 1994.
9. Cummings RD, Kornfeld S, Schneider WJ, Hobgood KK, Tolleshaug
H, Brown MS, Goldstein JL. Biosynthesis of N- and O-linked oligosac-
charides of the low density lipoprotein receptor. J Biol Chem 258:
15261–15273, 1983.
10. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM.
Correlation of hormones with lipid and lipoprotein levels during normal
pregnancy and postpartum. J Clin Endocrinol Metab 64: 704–712, 1987.
11. Gafvels ME, Coukos G, Sayegh R, Coutifaris C, Strickland DK,
Strauss JF 3rd. Regulated expression of the trophoblast alpha 2-macro-
globulin receptor/low density lipoprotein receptor-related protein. Differ-
entiation and cAMP modulate protein and mRNA levels. J Biol Chem 267:
21230–21234, 1992.
12. Hiden U, Maier A, Bilban M, Ghaffari-Tabrizi N, Wadsack C, Lang
I, Dohr G, Desoye G. Insulin control of placental gene expression shifts
from mother to foetus over the course of pregnancy. Diabetologia 49:
123–131, 2006.
13. Lasuncion MA, Bonet B, Knopp RH. Mechanism of the HDL2 stimu-
lation of progesterone secretion in cultured placental trophoblast. J Lipid
Res 32: 1073–1087, 1991.
14. Lin DS, Pitkin RM, Connor WE. Placental transfer of cholesterol into
the human fetus. Am J Obstet Gynecol 128: 735–739, 1977.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measure-
ment with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951.
16. Malassine A, Besse C, Roche A, Alsat E, Rebourcet R, Mondon F,
Cedard L. Ultrastructural visualization of the internalization of low
E483LIPOPROTEIN RECEPTOR EXPRESSION IN IUGR
AJP-Endocrinol Metab • VOL 292 • FEBRUARY 2007 • www.ajpendo.org
 on January 10, 2008 
ajpendo.physiology.org
Downloaded from
 
density lipoprotein by human placental cells. Histochemistry 87: 457–464,
1987.
17. McNamara JR, Small DM, Li Z, Schaefer EJ. Differences in LDL
subspecies involve alterations in lipid composition and conformational
changes in apolipoprotein B. J Lipid Res 37: 1924–1935, 1996.
18. Murata M, Kodama H, Goto K, Hirano H, Tanaka T. Decreased
very-low-density lipoprotein and low-density lipoprotein receptor messen-
ger ribonucleic acid expression in placentas from preeclamptic pregnan-
cies. Am J Obstet Gynecol 175: 1551–1556, 1996.
19. Parazzini F, Cortinovis I, Bortolus R, Fedele L. [Standards of birth
weight in Italy]. Ann Ostet Ginecol Med Perinat 112: 203–246, 1991.
20. Pardi G, Cetin I, Marconi AM, Lanfranchi A, Bozzetti P, Ferrazzi E,
Buscaglia M, Battaglia FC. Diagnostic value of blood sampling in
fetuses with growth retardation. N Engl J Med 328: 692–696, 1993.
21. Pardi G, Marconi AM, Cetin I. Placental-fetal interrelationship in IUGR
fetuses—a review. Placenta 23, Suppl A: S136–S141, 2002.
22. Pedersen A, Baumstark MW, Marckmann P, Gylling H, Sandstrom
B. An olive oil-rich diet results in higher concentrations of LDL choles-
terol and a higher number of LDL subfraction particles than rapeseed oil
and sunflower oil diets. J Lipid Res 41: 1901–1911, 2000.
23. Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid
hormones in primate pregnancy. Endocr Rev 16: 608–648, 1995.
24. Pitkin RM, Connor WE, Lin DS. Cholesterol metabolism and placental
transfer in the pregnant Rhesus monkey. J Clin Invest 51: 2584–2592,
1972.
25. Plotz EJ, Kabara JJ, Davis ME, LeRoy GV, Gould RG. Studies on the
synthesis of cholesterol in the brain of the human fetus. Am J Obstet
Gynecol 101: 534–538, 1968.
26. Radunovic N, Kuczynski E, Rosen T, Dukanac J, Petkovic S, Lock-
wood CJ. Plasma apolipoprotein A-I and B concentrations in growth-
retarded fetuses: a link between low birth weight and adult atherosclerosis.
J Clin Endocrinol Metab 85: 85–88, 2000.
27. Rigotti A, Trigatti B, Babitt J, Penman M, Xu S, Krieger M. Scavenger
receptor BI—a cell surface receptor for high density lipoprotein. Curr
Opin Lipidol 8: 181–188, 1997.
28. Rodie VA, Caslake MJ, Stewart F, Sattar N, Ramsay JE, Greer IA,
Freeman DJ. Fetal cord plasma lipoprotein status in uncomplicated
human pregnancies and in pregnancies complicated by pre-eclampsia and
intrauterine growth restriction. Atherosclerosis 176: 181–187, 2004.
29. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal
plasma volume and hormonal changes in women with preeclampsia or
fetal growth restriction. Hypertension 47: 203–208, 2006.
30. Sattar N, Greer IA, Galloway PJ, Packard CJ, Shepherd J, Kelly T,
Mathers A. Lipid and lipoprotein concentrations in pregnancies compli-
cated by intrauterine growth restriction. J Clin Endocrinol Metab 84:
128–130, 1999.
31. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and
assessment of their peroxidation by high-performance liquid chromatog-
raphy postcolumn chemiluminescence. Methods Enzymol 233: 469–489,
1994.
32. Sparks DL, Phillips MC. Quantitative measurement of lipoprotein sur-
face charge by agarose gel electrophoresis. J Lipid Res 33: 123–130, 1992.
33. Spellacy WN, Ashbacher LV, Harris GK, Buhi WC. Total cholesterol
content in maternal and umbilical vessels in term pregnancies. Obstet
Gynecol 44: 661–665, 1974.
34. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Despres
JP, Lamarche B. Comparison of various electrophoretic characteristics of
LDL particles and their relationship to the risk of ischemic heart disease.
Circulation 104: 2295–2299, 2001.
35. Stepan H, Faber R, Walther T. Expression of low density lipoprotein
receptor messenger ribonucleic acid in placentas from pregnancies with
intrauterine growth retardation. Br J Obstet Gynaecol 106: 1221–1222,
1999.
36. Umans L, Overbergh L, Serneels L, Tesseur I, Van Leuven F. Analysis
of expression of genes involved in apolipoprotein E-based lipoprotein
metabolism in pregnant mice deficient in the receptor-associated protein,
the low density lipoprotein receptor, or apolipoprotein E. Biol Reprod 61:
1216–1225, 1999.
37. Vedie B, Jeunemaitre X, Megnien JL, Myara I, Trebeden H, Simon A,
Moatti N. Charge heterogeneity of LDL in asymptomatic hypercholester-
olemic men is related to lipid parameters and variations in the ApoB and
CIII genes. Arterioscler Thromb Vasc Biol 18: 1780–1789, 1998.
38. Wadsack C, Hammer A, Levak-Frank S, Desoye G, Kozarsky KF,
Hirschmugl B, Sattler W, Malle E. Selective cholesteryl ester uptake
from high density lipoprotein by human first trimester and term villous
trophoblast cells. Placenta 24: 131–143, 2003.
39. Winkel CA, Snyder JM, MacDonald PC, Simpson ER. Regulation of
cholesterol and progesterone synthesis in human placental cells in culture
by serum lipoproteins. Endocrinology 106: 1054–1060, 1980.
40. Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baum-
stark MW, Wieland H, Marz W, Zahradnik HP. Low density lipopro-
tein (LDL) subfractions during pregnancy: accumulation of buoyant LDL
with advancing gestation. J Clin Endocrinol Metab 85: 4543–4550, 2000.
41. Wittmaack FM, Gafvels ME, Bronner M, Matsuo H, McCrae KR,
Tomaszewski JE, Robinson SL, Strickland DK, Strauss JF 3rd. Lo-
calization and regulation of the human very low density lipoprotein/
apolipoprotein-E receptor: trophoblast expression predicts a role for the
receptor in placental lipid transport. Endocrinology 136: 340–348, 1995.
42. Woollett LA. The origins and roles of cholesterol and fatty acids in the
fetus. Curr Opin Lipidol 12: 305–312, 2001.
43. Wyne KL, Woollett LA. Transport of maternal LDL and HDL to the fetal
membranes and placenta of the Golden Syrian hamster is mediated by
receptor-dependent and receptor-independent processes. J Lipid Res 39:
518–530, 1998.
44. Yano M, Inoue M, Maehata E, Shiba T, Yamakado M, Hirabayashi Y,
Taniyama M, Suzuki S. Increased electronegative charge of serum
low-density lipoprotein in patients with diabetes mellitus. Clin Chim Acta
340: 93–98, 2004.
45. Yoshimitsu N, Douchi T, Yamasaki H, Nagata Y, Andoh T, Hatano H.
Differences in umbilical cord serum lipid levels with mode of delivery.
Br J Obstet Gynaecol 106: 144–147, 1999.
E484 LIPOPROTEIN RECEPTOR EXPRESSION IN IUGR
AJP-Endocrinol Metab • VOL 292 • FEBRUARY 2007 • www.ajpendo.org
 on January 10, 2008 
ajpendo.physiology.org
Downloaded from
 
